Fluorinated piperidine acetic acids as γ-secretase modulators (original) (raw)

A Substrate-Based Difluoro Ketone Selectively Inhibits Alzheimer's γ-Secretase Activity

Michael Wolfe

Journal of Medicinal Chemistry, 1998

View PDFchevron_right

Discovery of 4-aminomethylphenylacetic acids as γ-secretase modulators via a scaffold design approach

Tina Talreja

Bioorganic & Medicinal Chemistry Letters, 2011

View PDFchevron_right

Lead optimization of 4,4-biaryl piperidine amides as γ-secretase inhibitors

Lina Xu, Flobert Tanga

Bioorganic & Medicinal Chemistry Letters, 2012

View PDFchevron_right

Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators

Ricardo Lira

Bioorganic & Medicinal Chemistry Letters, 2012

View PDFchevron_right

1-Amino-4,4-difluorocyclohexanecarboxylic acid as a promising building block for drug discovery: Design, synthesis and characterization

Pavel Mykhailiuk

2013

View PDFchevron_right

Synthesis of Pyridopyrazine-1,6-dione γ-Secretase Modulators via Selective 4-Methylimidazole N1-Buchwald Arylation

Neal Sach

The Journal of Organic Chemistry, 2019

View PDFchevron_right

Discovery of 2,4,6-trisubstituted N-arylsulfonyl piperidines as γ-secretase inhibitors

Amin Nomeir

Bioorganic & Medicinal Chemistry Letters, 2007

View PDFchevron_right

Purine derivatives as potent γ-secretase modulators

Yudith Garcia

Bioorganic & Medicinal Chemistry Letters, 2010

View PDFchevron_right

N-Bridged bicyclic sulfonamides as inhibitors of γ-secretase

Gary Probst

Bioorganic & Medicinal Chemistry Letters, 2009

View PDFchevron_right

Pyridine-derived γ-secretase modulators

Adrian Hall

Bioorganic & Medicinal Chemistry Letters, 2011

View PDFchevron_right

N-{N-[2-(3,5-Difluorophenyl)acetyl]-(S)-alanyl}-(S)-phenylglycinetert-butyl ester (DAPT): an inhibitor of γ-secretase, revealing fine electronic and hydrogen-bonding features

Francisco Valenzuela

Acta Crystallographica Section C Crystal Structure Communications, 2010

View PDFchevron_right

Discovery of a novel sulfonamide-pyrazolopiperidine series as potent and efficacious γ-secretase inhibitors (Part II)

Martin Neitzel, Elizabeth Brigham, Jacek Jagodzinski

Bioorganic & Medicinal Chemistry Letters, 2010

View PDFchevron_right

1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic Acid (CHF5074), a Novel -Secretase Modulator, Reduces Brain beta-Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease without Causing Peripheral Toxicity

Vladimiro Pietrini

Journal of Pharmacology and Experimental Therapeutics, 2007

View PDFchevron_right

Discovery and initial optimization of 5,5′-disubstituted aminohydantoins as potent β-secretase (BACE1) inhibitors

Kristi Fan, Ann Aulabaugh

Bioorganic & Medicinal Chemistry Letters, 2010

View PDFchevron_right

New 4-Aminopyridine derivatives containing peptide fragment designed for the treatment of Alzheimer disease and multiple sclerosis

Borislav Anchev

Proceedings of the 35th European Peptide Symposium

View PDFchevron_right

Development of Fluorine-18-Labeled 5-HT1A Antagonists

Lixin Lang

Journal of Medicinal Chemistry, 1999

View PDFchevron_right

Novel orally active morpholine N-arylsulfonamides γ-secretase inhibitors with low CYP 3A4 liability

Amin Nomeir

Bioorganic & Medicinal Chemistry Letters, 2009

View PDFchevron_right

(S)-N-(5-Chlorothiophene-2-sulfonyl)-β,β-diethylalaninol a Notch-1-sparing γ-secretase inhibitor

Anthony Kreft

Bioorganic & Medicinal Chemistry Letters, 2009

View PDFchevron_right

Author's personal copy Practical syntheses of 4-fluoroprolines

Mukund Chorghade

View PDFchevron_right

Discovery of (S)-2-((S)-2-(3,5-difluorophenyl)-2-hydroxyacetamido)-N-((S,Z)-3-methyl-4-oxo-4,5-dihydro-3H-benzo[d][1,2]diazepin-5-yl)propanamide (BMS-433796): A γ-secretase inhibitor with Aβ lowering activity in a transgenic mouse model of Alzheimer’s disease

Suresh Yeola

Bioorganic & Medicinal Chemistry Letters, 2007

View PDFchevron_right

1-(3′, 4′-Dichloro-2-fluoro [1, 1′-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel γ-secretase modulator, reduces brain β-amyloid pathology in a …

B. Imbimbo

… of Pharmacology and …, 2007

View PDFchevron_right

Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease

Santosh Prajapati

European Journal of Medicinal Chemistry, 2019

View PDFchevron_right